Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects

European Journal of Clinical Nutrition

Volumn 64, Issue 4, 2010, Pages 424-431

  Jauhiainen, T ^a,b   Ronnback M ^a,c   Vapaatalo, H ^a   Wuolle, K ^b   Kautiainen, H ^d,e   Groop, P H ^a,c   Korpela, R ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VALIO LTD   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Central Finland Central Hospital   (Finland)

^e ORTON   (Finland)

Author keywords

Aortic augmentation index; Arterial stiffness; Bioactive peptides; Endothelial function; Hypertension; Pulse wave analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCERYL TRINITRATE; ISOLEUCYLPROLYLPROLINE; PLACEBO; SALBUTAMOL; TRIPEPTIDE; UNCLASSIFIED DRUG; VALYLPROLYLPROLINE; CASEIN; ISOLEUCYL-PROLYL-PROLINE; OLIGOPEPTIDE; VALYL-PROLYL-PROLINE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MONITORING; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ENDOTHELIUM CELL; FEMALE; FERMENTED PRODUCT; HUMAN; HYPERTENSION; LACTOBACILLUS HELVETICUS; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MILK; PATIENT COMPLIANCE; PULSE WAVE; ANIMAL; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; FERMENTATION; FOOD CONTROL; METABOLISM; MICROBIOLOGY; MIDDLE AGED; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ADULT; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CASEINS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FERMENTATION; FOOD MICROBIOLOGY; HUMANS; HYPERTENSION; LACTOBACILLUS HELVETICUS; MALE; MIDDLE AGED; MILK; OLIGOPEPTIDES; RADIAL ARTERY;

LACTOBACILLUS HELVETICUS;

EID: 77950628222     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.3     Document Type: Article

References (43)

1. Ahimastos AA, Natoli AK, Lawler A, Blombery PA, Kingwell BA (2005). Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertens 45, 1194-1199.
2. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. (2002). Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertens 39, 10-15.
3. Chen C, Nevo E, Fetics B, Pak P, Yin F, Maughan W et al. (1997). Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 95, 1827-1836.
4. Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ et al. (2005). Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertens 45, 980-985.
5. Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM (2008). Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension 51, 399-405.
6. FitzGerald RJ, Murray BA, Walsh DJ (2004). Hypotensive peptidesa from milk proteins. J Nutr 134, 980-988.
7. Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM, Kloek J (2007). Angiotensin converting enzyme inhibitory peptides from a lactotripeptide- enriched milk beverage are absorbed intact into the circulation. J Nutr 137, 953-958.
8. Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
9. Hirota T, Ohki K, Kawagishi R, Kajimoto Y, Mizuno S, Nakamura Y et al. (2007). Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res 30, 489-496.
10. Hong F, Ming L, Yi S, Zhanxia L, Yongquan W, Chi L (2008). The antihypertensive effect of peptides: a novel alternative to drugs? Peptides 29, 1062-1071.
11. Jäkälä P, Jauhiainen T, Korpela R, Vapaatalo H (2009). Milk proteinderived bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro protect endothelial function in vitro in spontaneously hypertensive rats. JFF 1, 266-273.
12. Jauhiainen T, Rönnback M, Vapaatalo H, Wuolle K, Kautiainen H, Korpela R (2007a). Lactobacillus helveticus fermented milk reduces arterial stiffness in hypertensive subjects. Int Dairy J 17, 1209-1211.
13. Jauhiainen T, Vapaatalo H, Poussa T, Kyrönpalo S, Rasmussen M, Korpela R (2005). Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 18, 1600-1605.
14. Jauhiainen T, Wuolle K, Vapaatalo H, Kerojoki O, Nurmela K, Lowrie C et al. (2007b). Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk derived antihypertensive peptide Ile-Pro-Pro in the rat. Int Dairy J 17, 1216-1223.
15. Jones PJ, MacDougall DE, Ntanios F, Vanstone CA (1997). Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 75, 217-227.
16. Korhonen H (2009). Milk-derived bioactive peptides: from science to applications. JFF 1, 177-187.
17. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. (2001). Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertens 37, 1236-1241.
18. Libby P, Aikawa M, Kinlay S, Selwyn A, Ganz P (2000). Lipid lowering improves endothelial functions. Int J Cardiol 74 (Suppl 1), S3-S10.
19. London G, Guerin A, Pannier B, Marchais S, Benetos A, Safar M (1992). Increased systolic pressure in chronic uremia. Role of arterial wave reflections. Hypertens 20, 10-19.
20. López-Fandiño R, Otte J, van Camp J (2006). Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J 16, 1277-1293.
21. Mäkynen H, Kähonen M, Arvola P, Wuorela H, Vapaatalo H, Pörsti I (1995). Dietary calcium and magnesium supplements in spontaneously hypertensive rats and isolated arterial reactivity. Br J Pharmacol 115, 1455-1462.
22. Mäkynen H, Kähönen M,Wu X, Arvola P, Pörsti I (1996). Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation. Circulation 93, 1000-1008.
23. Masuda O, Nakamura Y, Takano T (1996). Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126, 3063-3068.
24. Mervaala EM, Paakkari I, Laakso J, Nevala R, Teravainen TM, Fyhrquist F et al. (1994). Replacement of salt by a novel potassiumand magnesium-enriched salt alternative improves the cardiovascular effects of ramipril. Br J Pharmacol 111, 1189-1197. (Pubitemid 24148790)
25. Nakamura Y, Masuda O, Takano T (1996). Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotechnol Biochem 60, 488-489.
26. Narkiewicz K, Kjeldsen SE, Oparil S, Hedner T (2007). Hypertension ans cardiovascular disease: Is arterial stiffness the heart of the matter? Blood Pressure 16, 236-237.
27. O'Rourke MF, Gallagher DE (1996). Pulse wave analysis. J Hypertens Suppl 14, S147-S157.
28. Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE (1990). Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323, 22-27.
29. Pripp AH (2008). Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res 52, 1-9.
30. Selmer RM, Kristiansen IS, Haglerod A, Graff-Iversen S, Larsen HK, Meyer HE et al. (2000). Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health 54, 697-702.
31. Seppo L, Jauhiainen T, Poussa T, Korpela R (2003). A fermented milk high in bioactive peptides has a blood pressure lowering effect in hypertensive subjects. Am J Clin Nutr 77, 326-330.
32. Sipola M, Finckenberg P, Korpela R, Vapaatalo H, Nurminen M-L (2002a). Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res 69, 103-111.
33. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H, Nurminen M-L (2001). Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol 52, 745-754.
34. Sipola M, Finckenberg P, Vapaatalo H, Pihlanto-Leppala A, Korhonen H, Korpela R et al. (2002b). Alpha-lactorphin and beta-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci 71, 1245-1253.
35. Tolvanen JP, Makynen H, Wu X, Hutri-Kahonen N, Ruskoaho H, Karjala K et al. (1998). Effects of calcium and potassium supplements on arterial tone in vitro in spontaneously hypertensive rats. Br J Pharmacol 124, 119-128.
36. van der Zander K, Bots ML, Bak AA, Koning MM, de Leeuw PW (2008). Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am J Clin Nutr 88, 1697-1702.
37. Vapaatalo H, Mervaala E (2001). Clinically important factors influencing endothelial function. Med Sci Monit 7, 1075-1085.
38. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I (2002). Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106, 1439-1441.
39. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MVet al. (2002). A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106, 913-919.
40. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ et al. (2002a). Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 22, 147-152.
41. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ (2000). The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525 (Part 1), 263-270.
42. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR (2002b). Nitric oxide regulates local arterial distensibility in vivo. Circulation 105, 213-217.
43. Xu JY, Qin LQ, Wang PY, Li W, Chang C (2008). Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 24, 933-940.